- POSITIVE
Quarterly Revenue TTK Healthcare Sep-2026 Quarterly Revenue is Rs 252 Cr which is growth of 13.3% YoY.
- POSITIVE
Quarterly Net Profit TTK Healthcare Sep-2026 Quarterly Net Profit is Rs 223 Cr which is growth of 993.7% YoY.
NSE: TTKHLTCARE | BSE: 507747
TTK Healthcare Live Share Price Today, Share Analysis and Chart
aboutTTK Healthcare Ltd. is a diversified consumer goods and healthcare company based in India. It operates across multiple business segments including consumer products, personal care, animal welfare, and medical devices. The company has a significant pr... Read More
1110.1557.65(5.48%)
361.2K
NSE+BSE Volume
NSE 20 Nov, 2026 3:31 PM
TTK Healthcare Stock Price Ranges
Day Price Range5.5% 1 Day return | 1110.2 (LTP) 1,065.81,138 LowHigh |
|---|---|
Week Price Range18.0% 1 Week return | 1110.2 (LTP) 920.21,138 LowHigh |
Month Price Range10.7% 1 Month return | 1110.2 (LTP) 8841,144.9 LowHigh |
52 Week Price Range-1.7% 1 Year return | 1110.2 (LTP) 7351,247 LowHigh |
Peers
Revenue Mix
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
TTK Healthcare quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 252.1 | 274.4 | 235.8 | 226.7 | 222.6 | 244.4 | 209.1 | 222.6 | 216.2 | 224.9 | 197.1 | 199.8 | 201.8 | ||
Operating Exp. | 229.6 | 242.8 | 207 | 202.2 | 198.2 | 223.8 | 178.4 | 197.1 | 190.3 | 201 | 168.6 | 178.5 | 176.2 | |
Operating Profit | 3.8 | 14.7 | 11 | 7.1 | 5.3 | 2.7 | 12 | 7.7 | 8.2 | 6.9 | 12.4 | 5.3 | 9.5 | |
Operating Profit Margin % | 1.60% | 5.72% | 5.06% | 3.41% | 2.62% | 1.18% | 6.31% | 3.76% | 4.15% | 3.32% | 6.86% | 2.90% | 5.13% | |
Depr. | 2.2 | 2.1 | 2.1 | 2.2 | 2.2 | 2.2 | 2.2 | 2.1 | 2 | 2.1 | 3.3 | 3.3 | 3.3 | |
Interest | 0.6 | 0.5 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 0.8 | 0.7 | 0.9 | 0.9 | 0.2 | 0.7 | |
Profit Before Tax | 267.9 | 28.9 | 29.5 | 14.1 | 21.3 | 17.7 | 21.8 | 22.6 | 23.2 | 40.8 | 24.2 | 17.7 | 21.6 | |
Tax | 45 | 7.6 | 7.8 | 3.6 | 0.9 | 4.7 | 5.6 | 5.9 | 6 | 9.2 | 6 | 4.8 | 5.6 | |
Net Profit | 223 | 21.3 | 21.8 | 10.5 | 20.4 | 13 | 16.2 | 16.7 | 17.2 | 31.6 | 18.3 | 12.9 | 16 | |
EPS Adj. latest | 157.8 | 15.1 | 15.4 | 7.5 | 14.4 | 9.2 | 11.4 | 11.8 | 12.2 | 22.4 | 12.9 | 9.1 | 11.3 | |
Net profit TTM | 276.6 | 74 | 65.7 | 60.1 | 66.3 | 63.1 | 81.7 | 83.8 | 79.9 | 78.8 | 62.8 | 61.5 | 60.6 | |
Basic EPS TTM | 195.7 | 52.3 | 46.5 | 42.5 | 46.9 | 44.6 | 57.8 | 59.3 | 56.6 | 55.7 | 44.5 | 43.5 | 42.9 | |
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
TTK Healthcare Technical Analysis
TTK Healthcare EMA & SMA
Bullish+8
Bullish8
Bearish0
| 5 Day | 1051.9 |
|---|---|
| 10 Day | 1015.6 |
| 12 Day | 1008.0 |
| 20 Day | 995.7 |
| 26 Day | 995.4 |
|---|---|
| 50 Day | 1005.1 |
| 100 Day | 1006.9 |
| 200 Day | 1013.0 |
TTK Healthcare Delivery And Volume
Daily Avg. Delivery Volume %
20 Nov, 202623.5%
Week17.5%
Month20.1%
TTK Healthcare Active Candlesticks
Three Outside Uptrend Hikkake Uptrend
PositiveNeutralNegative
TTK Healthcare Resistance and Support
1104.63
Pivot
| First Resistance | 1143.5 |
|---|---|
| Second Resistance | 1176.9 |
| Third Resistance | 1215.8 |
| First Support | 1071.3 |
|---|---|
| Second Support | 1032.4 |
| Third Support | 999.0 |
| Day RSI | 64.2 |
|---|---|
| Day MACD | 12.6 |
| Day MFI | 85.2 |
| Day MACD Signal Line | -9.3 |
TTK Healthcare Beta
| 1 Month | 0.5 |
|---|---|
| 1 Year | 0.7 |
| 3 Month | 0.8 |
|---|---|
| 3 Year | 0.6 |
TTK Healthcare Price Change Analysis
↑10.7%
Over 1 Month
LowHigh
8841144.9
↑1.0%
Over 3 Months
LowHigh
8841247
↑24.5%
Over 6 Months
LowHigh
852.11247
↓-1.7%
Over 1 Year
LowHigh
7351247
TTK Healthcare Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| UNO METALS LTD | Bulk | Sell | 17 Mar 2025 | 1124.24 | 76,500 | NSE |
| CLUBMILLIONAIRE FINANCIAL SERVICES PRIVATE LIMITED | Bulk | Sell | 31 Jul 2024 | 1541.13 | 87,335 | NSE |
| UNO METALS LTD | Bulk | Purchase | 31 Jul 2024 | 1541.59 | 97,513 | NSE |
| MCAP INDIA FUND LIMITED | Block | Sell | 24 Mar 2023 | 910 | 130,488 | BSE |
| MCAP INDIA FUND LIMITED | Block | Sell | 24 Mar 2023 | 910 | 115,385 | BSE |
| ABAKKUS DIVERSIFIED ALPHA FUND | Block | Purchase | 24 Mar 2023 | 910 | 115,385 | BSE |
| ABAKKUS ASSET MANAGER LLP | Block | Purchase | 24 Mar 2023 | 910 | 130,488 | BSE |
| ABAKKUS DIVERSIFIED ALPHA FUND | Bulk | Purchase | 24 Mar 2023 | 910 | 115,385 | BSE |
| ABAKKUS ASSET MANAGER LLP | Bulk | Purchase | 24 Mar 2023 | 911.08 | 131,788 | BSE |
| MCAP INDIA FUND LIMITED | Bulk | Sell | 24 Mar 2023 | 910 | 245,873 | BSE |
TTK Healthcare Corporate Actions
TTK Healthcare Dividend history and yield
TTK Healthcare dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track TTK Healthcare dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
117 Jul 2026 | 10 | FINAL | 17 Jul 2026 | Equity Share |
218 Jul 2025 | 10 | FINAL | 18 Jul 2025 | Equity Share |
316 Jul 2024 | 10 | FINAL | - | Equity Share |
418 Jul 2023 | 10 | FINAL | - | Equity Share |
526 Jul 2022 | 10 | FINAL | - | Equity Share |
TTK Healthcare Board Meetings
TTK Healthcare past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
120 Nov 2026 | Scheme of Arrangement | - |
230 Oct 2026 | Quarterly Results | - |
306 Aug 2026 | Quarterly Results | - |
430 May 2026 | Audited Results & Final Dividend | - |
522 Jan 2026 | Quarterly Results & Others | To consider other business matters. |
TTK Healthcare Rights issue
TTK Healthcare rights issue history, along with record, ex-rights dates, and rights ratios.
#Ex-Date | Ratio | Face Value | Premium | Record Date |
|---|---|---|---|---|
106 Oct 1992 | 2.0:5.0 | - | 35 | 28 Oct 1992 |
TTK Healthcare Research Reports
TTK Healthcare research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 116 May 2018 | Rudra Shares and Stock Brokers Ltd | 1090 | 928.2 | Buy | 17.43% | 19.6% |
TTK Healthcare Corporate Filings
TTK Healthcare BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 20 Nov 2026 | TTK Healthcare Ltd-$ - 507747 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement | Outcome of Board Meeting | |
| 20 Nov 2026 | TTK Healthcare Ltd-$ - 507747 - Board Meeting Outcome for Outcome Of Board Meeting | Scheme of Arrangement between TTK Healthcare Limited (the Company) and its Equity Shareholders under Section 230 and other applicable provisions, if any, of the Companies Act, 2013 | |
| 16 Nov 2026 | TTK Healthcare Ltd-$ - 507747 - Closure of Trading Window | Closure of Trading Window | |
| 16 Nov 2026 | TTK Healthcare Ltd-$ - 507747 - Board Meeting Intimation for Board Meeting Intimation | TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/11/2026 ,inter alia, to consider and approve Board Meeting Intimation | |
| 03 Nov 2026 | TTK Healthcare Ltd-$ - 507747 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Copy of Newspaper Publication |
TTK Healthcare Documents
TTK Healthcare Annual Reports
TTK Healthcare financials, including annual results, balance sheets, and cash flow statements.
TTK Healthcare Credit Ratings
TTK Healthcare credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
| Date | Rating Agency | Company Name | Description | Links |
|---|---|---|---|---|
| 21 Sep 2026 | icra ratings | TTK Healthcare Limited | Ratings reaffirmed | Link |
| 28 Sep 2025 | icra ratings | TTK Healthcare Limited | Ratings reaffirmed | Link |
| 28 Oct 2024 | icra ratings | TTK Healthcare Limited | Ratings reaffirmed; long-term rating removed from \u2018Rating Watch with Positive Implications\u2019 and \u2018Stable\u2019 outlook assigned | Link |
| 03 Sep 2023 | icra ratings | TTK Healthcare Limited | TTK Healthcare Limited: Long-term rating continues on Watch with Positive Implications; short-term rating reaffirmed | Link |
| 06 Jul 2022 | icra ratings | TTK Healthcare Limited | TTK Healthcare Limited: Long-term rating continues on watch with positive implications; short-term rating reaffirmed | Link |
TTK Healthcare Investor Presentations
TTK Healthcare investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 14 Sep 2016 | Corporate Presentation to be shared with the Investor(s) |
TTK Healthcare - Company Profile
TTK Healthcare Management Structure
TTK Healthcare management structure with salaries, total experience, and qualifications.
TTK Healthcare Board of Directors
TTK Healthcare Board of directors with salaries, total experience, and qualifications.
Website: www.ttkhealthcare.com
About the company - Business Profile
TTK Healthcare Ltd. is a diversified consumer goods and healthcare company based in India. It operates across multiple business segments including consumer products, personal care, animal welfare, and medical devices. The company has a significant presence in the Indian market with a portfolio of well-known brands and a robust distribution network.
Key Points
- Key facts: Founded in 1958, the company is headquartered in Chennai, Tamil Nadu. It is a part of the TTK Group. The company's equity shares are listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).
- Operations and resources: The company operates through several divisions: Consumer Products, Personal Care (brands like Eva), Animal Welfare, and Medical Devices. It maintains a widespread distribution network with depots in major cities including Ahmedabad, Bengaluru, Chennai, Delhi, Kolkata, and Mumbai.
- Privatization and ownership: As of the latest reporting period, the company remains a public listed entity within the TTK Group. There were prior discussions regarding voluntary delisting, but as of the FY2024-25 report, it remains listed.
- Market and significance: TTK Healthcare serves a wide range of industries including healthcare (medical devices like heart valves), consumer lifestyle (deodorants and personal care), and agriculture (animal health products). Its medical devices division, particularly the TTK Chitra Heart Valve, is strategically important for affordable cardiac care in India.
- Sustainability and innovation: The company has focused on upgrading its technology stack, including migrating to Oracle Apex version 23 and rolling out Sales Force Reporting systems. Environmental initiatives are tracked through its Business Responsibility and Sustainability Reporting (BRSR) frameworks.
- Business Model: The company utilizes a multi-divisional model to mitigate risks associated with any single industry. It excels in brand building within the personal care space and technical manufacturing in the medical devices sector.
Revenue and Financial Performance
For the financial year ended March 31, 2025, the company reported the following performance metrics (Annual numbers):
- Revenue from Operations: ₹801.49 crore (compared to ₹752.79 crore in FY2023-24).
- EBITDA: ₹119.98 crore (including exceptional items), up from ₹99.93 crore in the previous year.
- Profit After Tax (PAT): ₹81.66 crore (FY2024-25) compared to ₹62.84 crore (FY2023-24).
- Net Profit Margin: 10.24% in FY2024-25, an improvement from 8.41% in the prior year.
Key Products and Strategic Initiatives
- Personal Care: The Eva brand is a core driver, particularly its range of alcohol-free lip balms and deodorants. New product launches include the Eva Rock On and Roll-on variants.
- Medical Devices: Focus remains on the manufacturing and distribution of the Tilapia Chitra Heart Valve, which is a significant indigenous contribution to Indian medical technology.
- Animal Welfare: This division provides a range of pharmaceutical and nutritional products for livestock and poultry.
- Technology Advancements: The company implemented a standalone module in the shop floor automated using Oracle Apex and integrated an Expense Management System to improve operational efficiency.
Corporate Structure and Outlook
- Employee Count: The company is certified as a Great Place to Work. While specific headcount numbers fluctuate, the company emphasizes retention through its HR policies.
- Strategic Initiatives: Current focus is on deepening the penetration of the Eva brand into regional markets and enhancing the manufacturing capacity of the medical devices unit. The company is also working on optimizing its supply chain through its 27+ depots across India.
- Subsidiaries: The company operates primarily as a standalone entity with specific business units managing different product lines.
References
